The objective of the RRCA project is to produce and provide radionuclides to investigators for imaging and therapy research. It further provides the imaging facilities for in vivo and in vitro evaluation.

The RRCA is interested in both collaborative research and service projects involving the use of cyclotron-produced isotopes and imaging devices.

Our research emphasis is in the development of routine methods for the production of PET radionuclides, which include ⁷⁶Br, ⁷⁷Br, ¹²⁴I, ⁸⁶Y, ^94mTc, ⁶⁶Ga, ⁶⁰Cu, ⁶¹Cu, ⁶⁴Cu. We are currently producing ⁶⁴Cu on a routine basis and are developing techniques for the production of other positron producing nuclides. In addition to the production of the these radionuclides, we are developing novel radiopharmaceuticals utilizing these isotopes for both imaging and therapy.

Several of these radionuclides have positron energies higher than those commonly used for PET imaging. As part of our resource to the radiopharmaceutical community, we will characterize the interactions of these high-energy positron emitters with commercially available PET instruments.

Production and Application of "Non Standard" PET nuclides - Workshop